Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pimoule

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Annals of the New York Academy of Sciences|July 12, 1995
[3H]cirazoline as a tool for the characterization of imidazoline sitesI Angel, M Le Rouzic, C Pimoule, et al.
European Journal of Pharmacology|July 15, 1994
Expression of alpha 1-adrenoceptor subtypes in rat tissues: implications for alpha 1-adrenoceptor classificationC Faure, C Pimoule, S Arbilla, et al.
Life Sciences|January 1, 1994
Identification of alpha 1-adrenoceptor subtypes present in the human prostateC Faure, C Pimoule, G Vallancien, et al.
European Journal of Pharmacology|March 12, 1982
High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenalineR Raisman, M Sette, C Pimoule, et al.
European Journal of Pharmacology|November 11, 1983
Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's diseaseC Pimoule, H Schoemaker, F Javoy-Agid, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1985
Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons diseaseH Schoemaker, C Pimoule, S Arbilla, et al.
Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profileI Angel, H Schoemaker, S Arbilla, et al.
Biological Psychiatry|March 1, 1987
Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptineM F Poirier, A M Galzin, H Loo, et al.
British Journal of Pharmacology|August 1, 1993
Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tractF Lefèvre-Borg, S E O'Connor, H Schoemaker, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Annals of the New York Academy of Sciences|July 12, 1995
[3H]cirazoline as a tool for the characterization of imidazoline sitesI Angel, M Le Rouzic, C Pimoule, et al.
European Journal of Pharmacology|July 15, 1994
Expression of alpha 1-adrenoceptor subtypes in rat tissues: implications for alpha 1-adrenoceptor classificationC Faure, C Pimoule, S Arbilla, et al.
Life Sciences|January 1, 1994
Identification of alpha 1-adrenoceptor subtypes present in the human prostateC Faure, C Pimoule, G Vallancien, et al.
European Journal of Pharmacology|March 12, 1982
High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenalineR Raisman, M Sette, C Pimoule, et al.
European Journal of Pharmacology|November 11, 1983
Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's diseaseC Pimoule, H Schoemaker, F Javoy-Agid, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1985
Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons diseaseH Schoemaker, C Pimoule, S Arbilla, et al.
Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profileI Angel, H Schoemaker, S Arbilla, et al.
Biological Psychiatry|March 1, 1987
Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptineM F Poirier, A M Galzin, H Loo, et al.
British Journal of Pharmacology|August 1, 1993
Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tractF Lefèvre-Borg, S E O'Connor, H Schoemaker, et al.
Pageof 3